Octapharma
Octapharma AG is a family-owned global healthcare company based in Lachen, Switzerland, founded in 1983 by Wolfgang Marguerre. It is a leading manufacturer of human protein products, focusing on developing and producing medicines derived from human plasma and cell lines. The company aims to enhance the quality of life for patients, particularly those with hemophilia, by offering safer and higher-quality therapies. The product portfolio of Octapharma includes treatments in three main therapeutic areas: hematology, immunotherapy, and critical care. In hematology, the company provides therapies for hemophilia and bleeding disorders, utilizing innovative technologies for safety. Its immunotherapy products address primary immunodeficiency syndromes and immune thrombocytopenia. In critical care, Octapharma offers products like OctaplasLG, a treated human plasma for transfusions. With a commitment to innovation and quality, Octapharma serves hospitals, healthcare providers, and patients in over 120 countries, reaching hundreds of thousands of patients each year. The company continues to expand its manufacturing capabilities and invest in research to improve patient outcomes in various medical conditions.
Work at Octapharma in HR or recruiting? Claim this page
Headcount trend
Octapharma went from 466 employees in Oct 2024 to 498 in Sep 2026. Apr to Sep 2026: 5 people joined, 9 left.
Org structure
Headcount by department
H-1B sponsorship
This company sponsors H-1B visas
Peer reviews
Worked with someone at Octapharma?
Anonymous peer reviews on OffTheRecord
Similar companies
Octapharma FAQ
How many employees does Octapharma have?
Octapharma has about 498 employees, up 0.2% over the 3 months to Sep 2026.
What is Octapharma's revenue per employee?
Octapharma makes about $7.07M in revenue per employee, based on $3.52B annual revenue and 498 employees.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.